Astria Therapeutics, Inc. Common Stock (ATXS)
Astria Therapeutics, Inc. (ATXS) is a biotechnology company focused on developing treatments for rare autoimmune and allergic diseases. The company specializes in innovative therapies aimed at addressing unmet medical needs, particularly in the fields of immunology and inflammation.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| February 28, 2005 | $0.40 | 2005-03-29 | 2004-12-31 |
| February 28, 2004 | $0.36 | 2004-03-18 | 2003-12-31 |
Dividends Summary
- Astria Therapeutics, Inc. Common Stock has issued 2 dividend payments over the past 1 years
- The most recent dividend was paid 7543 days ago, on February 28, 2005
- The highest dividend payed out to investors during this period was $0.40 per share
- The average dividend paid during this period was $0.38 per share.
Company News
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies involving mergers and acquisitions.
BioCryst Pharmaceuticals announced it will acquire Astria Therapeutics for $700 million, adding a new product candidate (Navenibart) for hereditary angioedema treatment, with the deal expected to close in Q1 2026.
Here is how Artivion (AORT) and Astria Therapeutics, Inc. (ATXS) have performed compared to their sector so far this year.